nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—P2RY2—pericardium—dilated cardiomyopathy	0.148	0.306	CbGeAlD
Suramin—F2—cardial valve—dilated cardiomyopathy	0.112	0.232	CbGeAlD
Suramin—SIRT5—cardiac ventricle—dilated cardiomyopathy	0.0216	0.0446	CbGeAlD
Suramin—SIRT5—myocardium—dilated cardiomyopathy	0.0203	0.0419	CbGeAlD
Suramin—SIRT1—cardiac ventricle—dilated cardiomyopathy	0.0179	0.0369	CbGeAlD
Suramin—SIRT1—myocardium—dilated cardiomyopathy	0.0168	0.0348	CbGeAlD
Suramin—SIRT5—heart—dilated cardiomyopathy	0.0141	0.0293	CbGeAlD
Suramin—P2RX4—heart—dilated cardiomyopathy	0.0134	0.0277	CbGeAlD
Suramin—PLA2G2A—cardiac ventricle—dilated cardiomyopathy	0.0125	0.0259	CbGeAlD
Suramin—SIRT5—cardiac atrium—dilated cardiomyopathy	0.0121	0.025	CbGeAlD
Suramin—PLA2G4A—Enalapril—Lisinopril—dilated cardiomyopathy	0.012	1	CbGdCrCtD
Suramin—PLA2G2A—myocardium—dilated cardiomyopathy	0.0118	0.0243	CbGeAlD
Suramin—SIRT1—heart—dilated cardiomyopathy	0.0117	0.0243	CbGeAlD
Suramin—ARSA—heart—dilated cardiomyopathy	0.0116	0.024	CbGeAlD
Suramin—P2RX4—cardiac atrium—dilated cardiomyopathy	0.0114	0.0237	CbGeAlD
Suramin—RYR1—heart—dilated cardiomyopathy	0.0108	0.0224	CbGeAlD
Suramin—SIRT1—cardiac atrium—dilated cardiomyopathy	0.01	0.0207	CbGeAlD
Suramin—PLA2G2A—heart—dilated cardiomyopathy	0.00821	0.017	CbGeAlD
Suramin—PLA2G2A—cardiac atrium—dilated cardiomyopathy	0.00702	0.0145	CbGeAlD
Suramin—F2—heart—dilated cardiomyopathy	0.0062	0.0128	CbGeAlD
Suramin—PLA2G4A—heart—dilated cardiomyopathy	0.00571	0.0118	CbGeAlD
Suramin—SIRT1—Signaling events mediated by HDAC Class I—TNF—dilated cardiomyopathy	0.00139	0.00275	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.00138	0.00273	CbGpPWpGaD
Suramin—F2—Folate Metabolism—GPX1—dilated cardiomyopathy	0.00135	0.00268	CbGpPWpGaD
Suramin—ARSA—Metabolism—TAZ—dilated cardiomyopathy	0.00132	0.00261	CbGpPWpGaD
Suramin—PLA2G2A—MicroRNAs in cardiomyocyte hypertrophy—RAF1—dilated cardiomyopathy	0.00132	0.00261	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00129	0.00256	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—SOD2—dilated cardiomyopathy	0.00126	0.00251	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.00126	0.00249	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00125	0.00248	CbGpPWpGaD
Suramin—RYR1—Ion channel transport—RAF1—dilated cardiomyopathy	0.00124	0.00246	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00123	0.00243	CbGpPWpGaD
Suramin—PLA2G2A—Cardiac Hypertrophic Response—TNF—dilated cardiomyopathy	0.00121	0.00239	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—GPX1—dilated cardiomyopathy	0.00121	0.00239	CbGpPWpGaD
Suramin—SIRT1—Androgen receptor signaling pathway—EGFR—dilated cardiomyopathy	0.0012	0.00238	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.0012	0.00237	CbGpPWpGaD
Suramin—ARSA—Metabolism—SDHA—dilated cardiomyopathy	0.00119	0.00236	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00119	0.00235	CbGpPWpGaD
Suramin—PLA2G4A—Endothelins—RAC1—dilated cardiomyopathy	0.00118	0.00234	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.00117	0.00232	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00115	0.00229	CbGpPWpGaD
Suramin—PLA2G4A—PDGF Pathway—RAF1—dilated cardiomyopathy	0.00115	0.00227	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—RAC1—dilated cardiomyopathy	0.00114	0.00225	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00113	0.00223	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—NR3C2—dilated cardiomyopathy	0.00112	0.00222	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00112	0.00222	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—ITGB1—dilated cardiomyopathy	0.00112	0.00221	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00107	0.00213	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.00107	0.00212	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.00101	0.002	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000956	0.00189	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000951	0.00188	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000951	0.00188	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000951	0.00188	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.000941	0.00186	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.000941	0.00186	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000918	0.00182	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000918	0.00182	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00091	0.0018	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ANKRD1—dilated cardiomyopathy	0.000904	0.00179	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000899	0.00178	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000884	0.00175	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000879	0.00174	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000875	0.00173	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—ACE—dilated cardiomyopathy	0.000869	0.00172	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000863	0.00171	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000863	0.00171	CbGpPWpGaD
Suramin—PLA2G2A—MicroRNAs in cardiomyocyte hypertrophy—TNF—dilated cardiomyopathy	0.000861	0.00171	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000856	0.0017	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000854	0.00169	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—TAZ—dilated cardiomyopathy	0.00085	0.00168	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000849	0.00168	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000849	0.00168	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000834	0.00165	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000834	0.00165	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000827	0.00164	CbGpPWpGaD
Suramin—F2—Hemostasis—TTN—dilated cardiomyopathy	0.000818	0.00162	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000803	0.00159	CbGpPWpGaD
Suramin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—RAF1—dilated cardiomyopathy	0.000802	0.00159	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	0.000787	0.00156	CbGpPWpGaD
Suramin—PLA2G4A—Endothelins—RAF1—dilated cardiomyopathy	0.000782	0.00155	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000777	0.00154	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000775	0.00154	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—SDHA—dilated cardiomyopathy	0.000768	0.00152	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000768	0.00152	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—RAF1—dilated cardiomyopathy	0.000753	0.00149	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000751	0.00149	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TTN—dilated cardiomyopathy	0.000748	0.00148	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000733	0.00145	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000731	0.00145	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000727	0.00144	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.000724	0.00143	CbGpPWpGaD
Suramin—F2—Hemostasis—ACTN2—dilated cardiomyopathy	0.000709	0.00141	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000708	0.0014	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000706	0.0014	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—NPPA—dilated cardiomyopathy	0.000704	0.0014	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000693	0.00137	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—EGFR—dilated cardiomyopathy	0.000689	0.00136	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—RAC1—dilated cardiomyopathy	0.000681	0.00135	CbGpPWpGaD
Suramin—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—dilated cardiomyopathy	0.000672	0.00133	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00067	0.00133	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000664	0.00132	CbGpPWpGaD
Suramin—F2—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.000661	0.00131	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—TNF—dilated cardiomyopathy	0.000656	0.0013	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000656	0.0013	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000652	0.00129	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—ACTN2—dilated cardiomyopathy	0.000649	0.00129	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.000647	0.00128	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000641	0.00127	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000638	0.00126	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000631	0.00125	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000631	0.00125	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00063	0.00125	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000621	0.00123	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000608	0.00121	CbGpPWpGaD
Suramin—F2—Hemostasis—VCL—dilated cardiomyopathy	0.000603	0.0012	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000587	0.00116	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000574	0.00114	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000568	0.00113	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000555	0.0011	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—VCL—dilated cardiomyopathy	0.000552	0.00109	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—AGT—dilated cardiomyopathy	0.000551	0.00109	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000538	0.00107	CbGpPWpGaD
Suramin—F2—Folate Metabolism—TNF—dilated cardiomyopathy	0.000538	0.00107	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00052	0.00103	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—EGFR—dilated cardiomyopathy	0.000516	0.00102	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000516	0.00102	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000514	0.00102	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000513	0.00102	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00051	0.00101	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00051	0.00101	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000509	0.00101	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000501	0.000993	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000497	0.000984	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000495	0.000981	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000493	0.000976	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000493	0.000976	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000489	0.000969	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000485	0.000962	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000485	0.000962	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000481	0.000953	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000481	0.000953	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000474	0.000939	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000472	0.000936	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000472	0.000936	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000469	0.000929	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000467	0.000926	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000461	0.000914	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00046	0.000912	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000459	0.00091	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000458	0.000908	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000458	0.000907	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000457	0.000905	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—RAF1—dilated cardiomyopathy	0.000452	0.000895	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000451	0.000894	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000447	0.000886	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000443	0.000879	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000433	0.000858	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000432	0.000856	CbGpPWpGaD
Suramin—RYR1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000432	0.000856	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000429	0.000851	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000427	0.000847	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ANKRD1—dilated cardiomyopathy	0.000426	0.000844	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000411	0.000815	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—TAZ—dilated cardiomyopathy	0.0004	0.000793	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000392	0.000777	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000379	0.00075	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000372	0.000737	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00037	0.000732	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—SDHA—dilated cardiomyopathy	0.000362	0.000718	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000359	0.000712	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000351	0.000695	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000342	0.000677	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.000334	0.000663	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000324	0.000642	CbGpPWpGaD
Suramin—ARSA—Metabolism—GPX1—dilated cardiomyopathy	0.000324	0.000642	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000322	0.000638	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00032	0.000634	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00032	0.000633	CbGpPWpGaD
Suramin—ARSA—Metabolism—CD36—dilated cardiomyopathy	0.000316	0.000625	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000313	0.000621	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000313	0.00062	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000309	0.000612	CbGpPWpGaD
Suramin—F2—Hemostasis—ITGB1—dilated cardiomyopathy	0.000303	0.0006	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000294	0.000583	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000289	0.000572	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—ACE—dilated cardiomyopathy	0.000289	0.000572	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000286	0.000568	CbGpPWpGaD
Suramin—ARSA—Metabolism—AGT—dilated cardiomyopathy	0.000284	0.000563	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000279	0.000553	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—ITGB1—dilated cardiomyopathy	0.000277	0.000549	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000276	0.000547	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000272	0.000538	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000272	0.000538	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—AGT—dilated cardiomyopathy	0.000266	0.000528	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00026	0.000515	CbGpPWpGaD
Suramin—F2—Hemostasis—CD36—dilated cardiomyopathy	0.000258	0.000512	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000253	0.0005	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000247	0.000489	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000247	0.000489	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000245	0.000485	CbGpPWpGaD
Suramin—F2—Hemostasis—RAC1—dilated cardiomyopathy	0.000243	0.000482	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—CD36—dilated cardiomyopathy	0.000236	0.000468	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000229	0.000454	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000226	0.000447	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000226	0.000447	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—RAC1—dilated cardiomyopathy	0.000223	0.000441	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000222	0.000441	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000222	0.00044	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000221	0.000438	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000221	0.000437	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00022	0.000435	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000215	0.000426	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000215	0.000425	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.00021	0.000417	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00021	0.000416	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000209	0.000414	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—GPX1—dilated cardiomyopathy	0.000209	0.000414	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CD36—dilated cardiomyopathy	0.000203	0.000403	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000203	0.000403	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000198	0.000393	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000194	0.000384	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000192	0.000379	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00019	0.000376	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000185	0.000366	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—AGT—dilated cardiomyopathy	0.000183	0.000363	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—AGT—dilated cardiomyopathy	0.000183	0.000363	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00018	0.000357	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000173	0.000344	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000165	0.000326	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000164	0.000325	CbGpPWpGaD
Suramin—F2—Hemostasis—RAF1—dilated cardiomyopathy	0.000161	0.00032	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000154	0.000305	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00015	0.000297	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—RAF1—dilated cardiomyopathy	0.000148	0.000293	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000147	0.000291	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000146	0.000289	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000146	0.000289	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00014	0.000277	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000135	0.000268	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000133	0.000265	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000133	0.000264	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000133	0.000264	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000131	0.00026	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000131	0.00026	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000128	0.000253	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000127	0.000251	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000124	0.000246	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000122	0.000242	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00012	0.000238	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000112	0.000222	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000106	0.000211	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000102	0.000203	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GPX1—dilated cardiomyopathy	9.84e-05	0.000195	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.72e-05	0.000193	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CD36—dilated cardiomyopathy	9.58e-05	0.00019	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.26e-05	0.000184	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.13e-05	0.000181	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—AGT—dilated cardiomyopathy	8.62e-05	0.000171	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.47e-05	0.000168	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.35e-05	0.000166	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RAC1—dilated cardiomyopathy	8.25e-05	0.000164	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AGT—dilated cardiomyopathy	7.89e-05	0.000156	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RAC1—dilated cardiomyopathy	7.55e-05	0.00015	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AGT—dilated cardiomyopathy	7.21e-05	0.000143	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.35e-05	0.000126	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.81e-05	0.000115	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RAF1—dilated cardiomyopathy	5.47e-05	0.000108	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RAF1—dilated cardiomyopathy	5.01e-05	9.92e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—EGFR—dilated cardiomyopathy	3.75e-05	7.44e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.43e-05	6.8e-05	CbGpPWpGaD
